According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

The Active Pharmaceutical Ingredients Directory offers key market opportunities by providing extensive information on over 5,000 API companies and 25,000 executives worldwide. It connects users to ...

South Korean contract manufacturer ST Pharm has sealed a supply contract worth $56 million to provide active pharmaceutical ingredients (APIs) for an oligonucleotide therapeutic developed by an ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...

Indian drugmaker Mankind Pharma intends to add an active pharmaceutical ingredient (API) manufacturing facility to its network of 16 production plants in India. The company says it will invest about ...

Cadila Pharmaceuticals inaugurated a Rs. 200 crore API plant in Dahej. The plant, equipped with advanced DCS automation technology, aims to enhance pharmaceutical production. The facility is designed ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Sterling Pharma Solutions has acquired Alcami’s API facility in Germantown, WI. Sterling Pharma Solutions, a global contract development and manufacturing organization, has announced, in a Sept. 30, ...

NewsVoir Mumbai (Maharashtra) [India], October 12: Flawless Pharma Pvt. Ltd. has engaged with a major European contract development and manufacturing organization (CDMO) & a leading African firm in ...

BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...